Preclinical Efficacy of a PSMA-targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-19-2268
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

225Ac-Psma-617 for PSMA-Targeted -Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Terbium-161 for PSMA-targeted Radionuclide Therapy of Prostate Cancer

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2019English

Alpha-Pet for Prostate Cancer: Preclinical Investigation Using 149Tb-Psma-617

Scientific Reports
Multidisciplinary
2019English

Targeted Α-Therapy of Metastatic Castration-Resistant Prostate Cancer With225Ac-Psma-617: Dosimetry Estimate and Empiric Dose Finding

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

In Vitro and in Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

64Cu-Psma-617: A Novel PSMA-targeted Radio-Tracer for PET Imaging in Gastric Adenocarcinoma Xenografted Mice Model

Oncotarget
Oncology
2017English

Preclinical Evaluation and Pilot Clinical Study of Al18F-Psma-BCH for Prostate Cancer Imaging

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Synergistic Effect of a Mesothelin Targeted Thorium-227 Conjugate in Combination With DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy